Good reasons to correct gap in utilisation of an old faithful

Atkinson, Chris
November 2013
New Zealand Doctor;11/6/2013, p13
The article looks at the aid of innovation advances in improving precision of radiation oncology. It explores innovation of radiation therapy in treating cancer in New Zealand as well as highlights the significance of accuracy through sophisticated planning systems in better targeting tumours in three dimension. The lack of evidence of the efficacy of radiation oncology is discussed.


Related Articles

  • When to Consider Radiation Therapy for Your Patient. TISDALE, BERNARD A. // American Family Physician;3/1/1999, Vol. 59 Issue 5, p1177 

    Offers guidelines that family physicians need to consider prior to the administration of radiation therapy to cancer patients. Mechanism of action; Approach to treatment planning; Side effects of radiation therapy; Specific potential uses of radiation therapy.

  • Stereotactic radiotherapy for oligometastatic cancer: a prognostic model for survival. de Vin, T.; Engels, B.; Gevaert, T.; Storme, G.; De Ridder, M. // Annals of Oncology;Feb2014, Vol. 25 Issue 2, p467 

    Stereotactic radiotherapy is a safe and locally effective treatment for patients with inoperable oligometastases. The challenge remains identifying subsets of patients that benefit in terms of overall survival. A prognostic model is presented based on four independent clinical risk factors:...

  • An investigation of anxiety about radiotherapy deploying the Radiotherapy Categorical Anxiety Scale. Shimotsu, Sakie; Karasawa, Kumiko; Kawase, Eri; Ito, Kana; Saito, Anneyuko; Izawa, Hiromi; Horikawa, Naoshi // International Journal of Clinical Oncology;Oct2010, Vol. 15 Issue 5, p457 

    Background: Radiotherapy is one of the major methods for treating cancer, but many patients undergoing radiotherapy have deep concerns about receiving radiation treatment. This problem is not generally appreciated and has not been adequately studied. Methods: The objective of this investigation...

  • Targeting the Epidermal Growth Factor Pathway as Therapy for Glioblastoma. Quant, Eudocia C.; Nutt, Catherine L.; Wang, Daphne; Batchelor, Tracy T. // Current Cancer Therapy Reviews;2011, Vol. 7 Issue 1, p65 

    Glioblastoma (GBM) is the most common malignant primary brain tumor in adults. Despite therapy with surgery, radiation and chemotherapy, the prognosis remains poor, and the demand for more effective treatments is high. Research has increased our understanding of the molecular pathways important...

  • Targeting fibroblast growth factor receptor 3 enhances radiosensitivity in human squamous cancer cells. Uzawa, K; Ishigami, T; Fushimi, K; Kawata, T; Shinozuka, K; Kasamatsu, A; Sakamoto, Y; Ogawara, K; Shiiba, M; Bukawa, H; Ito, H; Tanzawa, H // Oncogene;10/27/2011, Vol. 30 Issue 43, p4447 

    Conventional therapies including radiation therapy cannot cure squamous cell carcinoma (SCC), and new treatments are clearly required. Our recent studies have shown that SCC cell lines exhibiting radioresistance show significant upregulation of the fibroblast growth factor receptor 3 (FGFR3)...

  • Radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma. Chassot, Andrea; Canale, Sandra; Varlet, Pascale; Puget, Stephanie; Roujeau, Thomas; Negretti, Laura; Dhermain, Frederic; Rialland, Xavier; Raquin, Marie; Grill, Jacques; Dufour, Christelle // Journal of Neuro-Oncology;Jan2012, Vol. 106 Issue 2, p399 

    The purpose of this study is to evaluate the efficacy and toxicity of radiation therapy (RT) with concurrent temozolomide (TMZ) chemotherapy followed by adjuvant TMZ in children with diffuse intrinsic pontine glioma (DIPG). Newly diagnosed patients younger than 18 years with histologically...

  • The Impact of Distant Metastases at Presentation on Prognosis in Patients with Differentiated Carcinoma of the Thyroid Gland. Nixon, Iain J.; Whitcher, Monica M.; Palmer, Frank L.; Tuttle, R. Michael; Shaha, Ashok R.; Shah, Jatin P.; Patel, Snehal G.; Ganly, Ian // Thyroid;Sep2012, Vol. 22 Issue 9, p884 

    Background: Distant metastases at presentation are rare in well-differentiated thyroid cancer (WDTC). The objective of this study was to report outcomes for patients presenting with distant metastases managed by thyroidectomy and radioactive iodine (RAI) therapy. Methods: Fifty-two patients with...

  • Prognostic factors and treatment outcome after radiotherapy in cervical cancer patients with isolated para-aortic lymph node metastases. Hyunsoo Jang; Mison Chun; Oyeon Cho; Jae Sung Heo; Hee-Sug Ryu; Suk-Joon Chang // Journal of Gynecologic Oncology;Jul2013, Vol. 24 Issue 3, p229 

    Objective: The purpose of the present study was to evaluate treatment outcomes and prognostic factors in cervical cancer patients with isolated para-aortic lymph node (PALN) metastases. We especially tried to evaluate PALN factors such as size, site and number. Methods: From August 1994 to...

  • Long-term outcomes of three-dimensional conformal radiation therapy combined with neoadjuvant hormonal therapy for Japanese patients with T1c-T2N0M0 prostate cancer. Mizowaki, Takashi; Takayama, Kenji; Norihisa, Yoshiki; Ogura, Masakazu; Kamba, Tomomi; Inoue, Takahiro; Shimizu, Yosuke; Kamoto, Toshiyuki; Ogawa, Osamu; Hiraoka, Masahiro // International Journal of Clinical Oncology;Dec2012, Vol. 17 Issue 6, p562 

    Background: The outcomes of three-dimensional conformal radiation therapy (3D-CRT) combined with neoadjuvant hormonal therapy (NAHT) in Japanese patients with T1c-T2N0M0 prostate cancer, with initiation of salvage hormonal therapy (SHT) at a relatively early phase, were analyzed. Methods:...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics